Global Pharmaceuticals & Biotech Most Popular Stocks

Eurofins Scientific

Market Cap: €10.6b

Provides various analytical testing and laboratory services worldwide.

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Mankind Pharma

Market Cap: ₹996.3b

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

Regencell Bioscience Holdings

Market Cap: US$11.4b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

CSPC Pharmaceutical Group

Market Cap: HK$88.1b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

BioMarin Pharmaceutical

Market Cap: US$11.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 104.8b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Zydus Lifesciences

Market Cap: ₹933.8b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Revvity

Market Cap: US$10.7b

Provides health sciences solutions, technologies, and services worldwide.

Exact Sciences

Market Cap: US$10.6b

Provides cancer screening and diagnostic test products in the United States and internationally.

Lupin

Market Cap: ₹895.1b

Operates as a pharmaceutical company in India and internationally.

ICON

Market Cap: US$10.4b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Viatris

Market Cap: US$10.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Moderna

Market Cap: US$10.3b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥72.3b

Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.

Sino Biopharmaceutical

Market Cap: HK$78.7b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Ascendis Pharma

Market Cap: US$9.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Ipsen

Market Cap: €8.6b

Operates as a biopharmaceutical company worldwide.

Qiagen

Market Cap: US$9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Orion Oyj

Market Cap: €8.5b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Tempus AI

Market Cap: US$9.6b

Operates as a healthcare technology company.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$71.0b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Avantor

Market Cap: US$8.8b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Akeso

Market Cap: HK$67.3b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sichuan Kelun Pharmaceutical

Market Cap: CN¥61.3b

Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥61.1b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Medpace Holdings

Market Cap: US$8.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Corcept Therapeutics

Market Cap: US$8.2b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Eisai

Market Cap: JP¥1.1t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Aurobindo Pharma

Market Cap: ₹660.3b

A biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥55.2b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Abbott India

Market Cap: ₹651.6b

Operates as a pharmaceutical company in India.

Bio-Techne

Market Cap: US$7.6b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Roivant Sciences

Market Cap: US$7.5b

A clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of medicines and technologies.

Verona Pharma

Market Cap: US$7.4b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.